Cerenome, Inc.
CNSY· Nasdaq
Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0000950170-23-042363
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$1.48M | -$5.28M | -$2.80M | -$1.84M |
| EPS Diluted | -$0.59 | -$3.56 | -$0.25 | -$0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end